*Purpose: To establish the feasibility and evaluate the results and outcomes of a newly established totally robotic kidney transplant program.

*Methods: Retrospective review of a single center experience at living donor totally robotic kidney transplants performed between January to October 2020. We evaluated the recipient demographics, Donor/graft characteristics, Intraoperative details including Cold Ischemia time (CIT), Warm Ischemia Time (WIT), Complications, Length of stay (LOS), Pain scores per visual analogue scale (VAS) on day 0,1,3, average Urine output (UOP) on first postoperative day and creatinine at days 7-10.

*Results: A total of 5 totally robotic kidney transplants were performed during the established time frame. Recipient and donor characteristics are reported on table 1. The mean CIT was 51.2 minutes and the WIT was 43.6 minutes. Mean UOP on the first 12 hours was 7640 ml. The average VAS at day 0, 1 and 2 was 1.4, 3.2 and 3.6 respectively. Creatinine measurements between days 7-10 had a mean of 1.38mg/dl. The only recorded complication was acute cellular rejection type Banff 1A in one patient that resolved with standard medical management. The Average LOS was 5 days with no re-admissions or recorded wound complications.

*Conclusions: Our early experience with living donor totally robotic kidney transplant shows that after adequate candidate selection the use of this technique is safe with reproducible outcomes and no procedure related complications. Additionally we showed rapid recovery and excellent graft function. Further investigation with a bigger cohort of patients and comparison to other techniques as well as learning curve for training physicians is needed.”$$table_”

« Back to 2021 American Transplant Congress